Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)

SHE:300039 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	593.31	601.94	694.69	1,345	1,307
Short-Term Investments	-	-	-	58.32	36.13
Trading Asset Securities	180.02	150.01	136.07	51.26	114.65
Cash & Short-Term Investments	773.33	751.95	830.76	1,455	1,458
Cash Growth	2.84%	-9.49%	-42.88%	-0.23%	8.09%
Accounts Receivable	471.99	529.32	530.33	567.99	528.76
Other Receivables	0.12	0.41	35.77	46.77	32.32
Receivables	472.12	529.74	566.09	614.76	562.39
Inventory	187.85	171.79	160.8	165.14	191.54
Other Current Assets	982.07	21.4	16.77	19.99	8.08
Total Current Assets	2,415	1,475	1,574	2,254	2,220
Property, Plant & Equipment	267.85	290.09	304.66	307.78	295.87
Long-Term Investments	1,075	1,310	1,312	711.06	280.24
Goodwill	-	-	9.04	13.79	18.5
Other Intangible Assets	168.8	45.11	44.23	42.9	45.26
Long-Term Deferred Tax Assets	29.44	31.61	18.26	15.1	17.55
Long-Term Deferred Charges	2.44	0.21	0.32	-	-
Other Long-Term Assets	559.67	1,428	996.49	10.75	-
Total Assets	4,518	4,580	4,259	3,356	2,877
Accounts Payable	99.37	134.85	91.01	75.02	62.23
Accrued Expenses	1.08	23.27	29.69	15.92	13.47
Short-Term Debt	5.42	-	-	-	35.72
Current Income Taxes Payable	57.29	41.08	35.54	3.47	8.82
Current Unearned Revenue	18.12	45.69	40.04	2.88	1.75
Other Current Liabilities	51.02	89.96	99.67	93.39	115.56
Total Current Liabilities	232.3	334.85	295.96	190.68	237.55
Long-Term Unearned Revenue	48.03	43.26	39.51	47.16	51.53
Long-Term Deferred Tax Liabilities	135.11	168.71	162.77	73.06	9.88
Total Liabilities	415.45	546.82	498.24	310.9	298.96
Common Stock	1,046	1,046	1,046	1,046	1,046
Additional Paid-In Capital	8.62	8.62	8.62	8.62	8.62
Retained Earnings	2,323	2,050	1,785	1,577	1,468
Comprehensive Income & Other	724.5	926.33	921.98	413.53	55.68
Total Common Equity	4,102	4,031	3,762	3,045	2,578
Minority Interest	0.97	1.64	-0.72	-0	-
Shareholders' Equity	4,103	4,033	3,761	3,045	2,578
Total Liabilities & Equity	4,518	4,580	4,259	3,356	2,877
Total Debt	5.42	-	-	-	35.72
Net Cash (Debt)	767.91	751.95	830.76	1,455	1,422
Net Cash Growth	2.12%	-9.49%	-42.88%	2.28%	5.44%
Net Cash Per Share	0.73	0.72	0.79	1.39	1.36
Filing Date Shares Outstanding	1,045	1,046	1,046	1,046	1,046
Total Common Shares Outstanding	1,045	1,046	1,046	1,046	1,046
Working Capital	2,183	1,140	1,278	2,064	1,982
Book Value Per Share	3.92	3.85	3.60	2.91	2.46
Tangible Book Value	3,933	3,986	3,708	2,988	2,515
Tangible Book Value Per Share	3.76	3.81	3.55	2.86	2.40
Buildings	-	383.04	372.25	342.91	342.42
Machinery	-	441.06	427.9	407.9	400.23
Construction In Progress	-	0.52	6.18	34.15	1.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.